“…This is due to the experience of China, where access to CT was relatively easy at the outbreak of the pandemic [ 28 ], and the low sensitivity of CXR in revealing pulmonary involvement, particularly in the early stage of the disease [ 25 , 27 ]. Using RT-PCR as the gold standard, the sensitivity of CRX, which depends not only on the disease stage, but also on its severity, the prevalence of COVID-19 in the area, and the expertise of radiologists, with possible support of artificial intelligence (AI), differs widely from 41.7 to 90% and is still lower than CT (60 to 98%) [ 30 , 31 , 32 ]. The specificity, on the other hand, is between 33 and 60.6% [ 33 , 34 ].…”